StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.21BP/E –Yield –

OPKO Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

OPKO Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$123.38M. For fiscal 2025 it was -$178.54M. The highest annual figure on record is $164.02M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$178.54M–
FY2024Dec 31, 2024-$183.49M–
FY2023Dec 31, 2023-$28.20M–
FY2022Dec 31, 2022-$95.19M-348.3%
FY2021Dec 31, 2021$38.34M-2.9%
FY2020Dec 31, 2020$39.48M–
FY2019Dec 31, 2019-$172.52M–
FY2018Dec 31, 2018-$109.14M–
FY2017Dec 31, 2017-$92.08M-387.3%
FY2016Dec 31, 2016$32.05M-80.5%
FY2015Dec 31, 2015$164.02M–
FY2014Dec 31, 2014-$90.38M–
FY2013Dec 31, 2013-$55.65M–
FY2012Dec 31, 2012-$25.42M–
FY2011Dec 31, 2011-$18.50M–
FY2010Dec 31, 2010-$18.71M–
FY2009Dec 31, 2009-$23.46M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$43.50M–
Q1 FY2026Mar 31, 2026-$19.31M–
Q4 FY2025Dec 31, 2025-$25.92M–
Q3 FY2025Sep 30, 2025-$34.65M–
Q2 FY2025Jun 30, 2025-$83.42M–
Q1 FY2025Mar 31, 2025-$34.55M–
Q4 FY2024Dec 31, 2024-$44.41M–
Q3 FY2024Sep 30, 2024-$77.08M-332.8%
Q2 FY2024Jun 30, 2024-$26.44M–
Q1 FY2024Mar 31, 2024-$35.57M–
Q4 FY2023Dec 31, 2023-$38.29M–
Q3 FY2023Sep 30, 2023$33.11M–
Q2 FY2023Jun 30, 2023-$365.00K–
Q1 FY2023Mar 31, 2023-$22.65M–
Q4 FY2022Dec 31, 2022-$31.62M–
Q3 FY2022Sep 30, 2022-$32.24M-196.5%
Q2 FY2022Jun 30, 2022-$11.48M–
Q1 FY2022Mar 31, 2022-$19.86M-176.3%
Q4 FY2021Dec 31, 2021-$5.64M-116.5%
Q3 FY2021Sep 30, 2021$33.40M-47.0%
Q2 FY2021Jun 30, 2021-$15.45M–
Q1 FY2021Mar 31, 2021$26.04M–
Q4 FY2020Dec 31, 2020$34.26M–
Q3 FY2020Sep 30, 2020$63.01M–
Q2 FY2020Jun 30, 2020-$14.42M–
Q1 FY2020Mar 31, 2020-$43.37M–
Q4 FY2019Dec 31, 2019-$46.04M–
Q3 FY2019Sep 30, 2019-$23.87M–
Q2 FY2019Jun 30, 2019-$53.63M–
Q1 FY2019Mar 31, 2019-$48.99M–
Q4 FY2018Dec 31, 2018-$34.66M-1742.6%
Q3 FY2018Sep 30, 2018-$21.88M–
Q2 FY2018Jun 30, 2018-$17.08M–
Q1 FY2018Mar 31, 2018-$35.52M–
Q4 FY2017Dec 31, 2017$2.11M-93.0%
Q3 FY2017Sep 30, 2017-$37.61M–
Q2 FY2017Jun 30, 2017-$22.66M–
Q1 FY2017Mar 31, 2017-$33.92M–
Q4 FY2016Dec 31, 2016$30.31M–
Q3 FY2016Sep 30, 2016-$31.90M–

More OPKO Health figures

See a number that looks wrong?